Printer Friendly
The Free Library
14,588,435 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dutton Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Reiterated in Update Report by Dutton Associates.


EL DORADO El Dorado, legendary country of South America
El Dorado (ĕl`dərä`dō, –rā`–) [Span.,=the gilded man], legendary country of the Golden Man sought by adventurers in South America.
 HILLS, Calif. -- Dutton Associates updates its coverage of Trinity Biotech plc (Nasdaq:TRIB TRIB Tributary
TRIB Tire Retread Information Bureau
Trib Chicago Tribune Newspaper
TRIB Transfer Rate of Information Bits (ANSI formula for calculating throughput)
TRIB Transmission Rate of Information Bits
), maintaining its Strong Buy rating and a 12-month price target of $12.00. The 9-page report by Dutton Associates senior analyst Stephen L. Handley is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and Knobias and other leading financial portals Financial Portal

A website that provides a variety of financial data and information, acting as an information hub for clients who are individual investors requiring timely financial news and data to make their investment decisions.
. Trinity Biotech, headquartered in Bray, Ireland, develops, acquires, manufactures and markets diagnostic test products for the point-of-care and clinical laboratory segments of the diagnostic market. The Company reports its financial results in U.S. dollars. Through its own sales force as well as a network of international distributors and strategic partners, Trinity sells products in 80 countries. The broad line of over 500 different tests is used to detect infectious diseases infectious diseases: see communicable diseases. , sexually transmitted diseases Sexually transmitted diseases

Infections that are acquired and transmitted by sexual contact. Although virtually any infection may be transmitted during intimate contact, the term sexually transmitted disease is restricted to conditions that are largely
, blood coagulation disorders blood coagulation disorder,
n a disturbance in the normal clotting mechanism of the blood.
 and autoimmune diseases Autoimmune diseases
A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs.

Mentioned in: Complement Deficiencies, Premature Menopause
. Trinity Biotech's recent results have been excellent, and we believe that the Company will continue to post strong sales and earnings growth well beyond 2007.

About Dutton Associates

Dutton Associates is one of the largest independent investment research firms in the U.S. Its 28 senior analysts are primarily CFAs and have expertise in many industries. Dutton Associates provides continuing analyst coverage of 140 enrolled companies, and its research, estimates and ratings are carried in all the major databases serving institutions and online investors.

The current cost of enrollment in our one-year continuing research program is US $39,500 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $71,000 from the Company for 12 Research Reports with coverage commencing on 1/27/03. The Firm does not accept any equity compensation. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 30, 2006
Words:354
Previous Article:Dutton Associates Announces Investment Opinion: Telanetix, Inc. Strong Speculative Buy Rating Reiterated in Update Report by Dutton Associates.
Next Article:Dutton Associates Announces Investment Opinion: DXP Enterprises Strong Buy Rating Reiterated in Update Report by Dutton Associates.
Topics:



Related Articles
J.M. Dutton & Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Issued by Dutton & Associates.
Dutton & Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Maintained In Update Report By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Maintained by Dutton & Associates.
Dutton & Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Maintained By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Trinity Biotech Buy Rating Maintained by Dutton & Associates.
Dutton Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Maintained By Dutton Associates.
Dutton Associates Announces Investment Opinion: Trinity Biotech Strong Buy Rating Maintained By Dutton Associates.
Dutton Associates Announces Investment Opinion: MorphoSys AG Strong Speculative Buy Rating in Update Coverage by Dutton Associates.
Dutton Associates Announces Investment Opinion: Applied NeuroSolutions Strong Speculative Buy Rating Reiterated In Update Coverage By Dutton...
Dutton Associates Announces Investment Opinion: Telkonet Maintained At Strong Speculative Buy Rating; Quarterly Results Give Hint of Progress.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles